Our Approach
Our Pipeline
Investors
Team
News
Key PUBLICATIONS
Contact
Menu
Our Approach
Our Pipeline
Investors
Team
News
Key PUBLICATIONS
Contact
CSO Imre Berger presents Halo Therapeutics’ safe, self administered COVID antiviral at OBD Bioseeds London.
February 2, 2022
Prev
Previous
Nature Medicine: Omicron Escapes Monoclonal Treatments
Next
SARS-CoV-2 Spike protein binds to heart’s vascular cells potentially contributing to severe microvascular damage
Next
Our Approach
Our Pipeline
Investors
Team
News
Key PUBLICATIONS
Contact